Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UN Countries Make Bold Pledges On AMR, Including Funding For R&D Into New Drugs and Diagnostics

Executive Summary

During the high-level UN meeting on Sept. 21, all 193 member countries will sign a declaration in which they pledge to take concrete action on tackling antimicrobial resistance, including providing resources for research into new drugs, vaccines and diagnostics, and ensuring good stewardship of antibiotic use in both humans and animals.

You may also be interested in...



Evotec Leverages Infectious Diseases Space With Sanofi R&D Deal

Evotec's CEO tells Scrip its pact with Sanofi to develop an infectious disease pipeline could offer a commercially viable approach to battling the global AMR crisis.

Why Still Nothing For AMR? EMA Asks PRIME Scheme Applicants

The European Medicines Agency wants AMR drug developers to apply for entry on its priority medicine (PRIME) scheme.

O'Neill Warns Pharma Risks Backlash If Doesn't Engage In World AMR Pact

The globalized drugs industry needs to play ball and help find a solution to antimicrobial resistance or risk getting blamed for its failure and the resulting world health crisis.

Related Content

Topics

UsernamePublicRestriction

Register

PS119172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel